The University of Chicago Medicine is nationally recognized for its outstanding cancer care. Surgical oncologists here are recognized experts in the management of a wide range of tumors including cancers of the gastrointestinal tract, breast cancer, sarcomas and melanoma. Combining unrivaled surgical oncology expertise with state-of-the-art technology and minimally invasive techniques, we offer treatment to patients in need of routine cancer care as well as those considered "untreatable" at other institutions.
Treatment plans for each individual patient are designed by a multidisciplinary team of surgical, medical and radiation oncologists. Major cancer operations, such as liver resections, esophagectomy and the Whipple procedure, are routinely and safely performed at our center, even in those patients considered at high risk such as elderly patients or patients with co-existing heart conditions. While a cure is our primary objective, paramount to our mission is improving quality of life by maintaining dignity (e.g., breast-saving surgery) and preserving normal function (e.g., rectal-sparing surgery).
We are especially experienced and proficient in hyperthermic intraperitoneal chemotherapy (HIPEC) as a treatment option for adult cancers, including soft tissue sarcomas, desmoplastic small round cell tumors and other hard-to-see cancers of the abdomen.
In addition to our innovative surgical procedures, clinical trials at the University of Chicago allow cancer patients to benefit from new and emerging therapies that are not always widely available. Also bolstering our surgical oncology program are our cancer prevention and early detection, genetic counseling and support services. These programs give patients and families the guidance and support they need as they journey through treatment and into survivorship.